These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 863677)

  • 1. Skeletal muscle protease and glucocorticoid hormone receptors in muscle wasting conditions and muscular dystrophy.
    Mayer M; Shafrir E
    Isr J Med Sci; 1977 Feb; 13(2):139-46. PubMed ID: 863677
    [No Abstract]   [Full Text] [Related]  

  • 2. Muscular dystrophy and activation of proteinases.
    Kar NC; Pearson CM
    Muscle Nerve; 1978; 1(4):308-13. PubMed ID: 35747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of anabolic steroid on skeletal muscle.
    Rogozkin V
    Med Sci Sports; 1979; 11(2):160-3. PubMed ID: 491874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-binding capacity of troponin of skeletal muscle in various muscle diseases.
    Furukawa T; Peter JB
    Neurology; 1970 Apr; 20(4):414. PubMed ID: 5535072
    [No Abstract]   [Full Text] [Related]  

  • 5. Tissue culture studies of muscle disorders: Part 2. Biochemical studies, nerve-muscle culture, metabolic myopathies, and animal models.
    Witkowski JA
    Muscle Nerve; 1986 May; 9(4):283-98. PubMed ID: 3520307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle wasting in muscular dystrophy: decreased protein synthesis or increased degradation?
    Griggs RC; Rennie MJ
    Ann Neurol; 1983 Feb; 13(2):125-32. PubMed ID: 6338807
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on steroid receptors in human and rabbit skeletal muscle - clues to the understanding of the mechanism of action of anabolic steroids.
    Gustafsson JA; Saartok T; Dahlberg E; Snochowski M; Häggmark T; Eriksson E
    Prog Clin Biol Res; 1984; 142():261-90. PubMed ID: 6709658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
    Warnes DM; Tomas FM; Ballard FJ
    Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment problems using anabolic steroids in progressive muscular dystrophy].
    Badalian LO; Temin PA; Mukhin KIu
    Klin Med (Mosk); 1984 Nov; 62(11):23-9. PubMed ID: 6394898
    [No Abstract]   [Full Text] [Related]  

  • 10. NADH-2 cytochrome C reductase and cytochrome C oxidase in experimental muscle disorders.
    Dobson HL; Kasahara M
    Tex Rep Biol Med; 1964 Dec; 22():Suppl 1:890+. PubMed ID: 4284089
    [No Abstract]   [Full Text] [Related]  

  • 11. [Protein metabolism in progressive muscular dystrophy].
    Badalian LO; Temin PA; Rafanov VS; Dzhutova ED; Nikanorova MIu
    Klin Med (Mosk); 1983 Aug; 61(8):8-12. PubMed ID: 6358668
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucocorticoid antagonism by exercise and androgenic-anabolic steroids.
    Hickson RC; Czerwinski SM; Falduto MT; Young AP
    Med Sci Sports Exerc; 1990 Jun; 22(3):331-40. PubMed ID: 2199753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intensity of renewal of the protein fractions of myofibrils in the skeletal muscles and heart of rabbit in experimental muscular dystrophy (E-avitaminosis)].
    Pkhakadze GA
    Ukr Biokhim Zh; 1967; 39(4):381-5. PubMed ID: 5603088
    [No Abstract]   [Full Text] [Related]  

  • 14. [Protein metabolism disorders in hereditary muscular dystrophy in mice (proteins of skeletal muscle, myocardium and liver)].
    Badalian LO; Bondarenko ES; Lukoianov IuE; Revich GG
    Izv Akad Nauk SSSR Biol; 1969; 5():742-51. PubMed ID: 5372908
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity of human skeletal muscle tropomyosin.
    Giometti CS; Danon MJ
    Ann Neurol; 1985 Aug; 18(2):234-43. PubMed ID: 3899000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the components of the cAMP system in muscle tissue in progressive muscular dystrophy (Erb's form) and myasthenic myopathy].
    Kozlov AV; Korovkin BF; Lobzin VS; Shapkin VI
    Lab Delo; 1979; (8):468-9. PubMed ID: 89254
    [No Abstract]   [Full Text] [Related]  

  • 17. Protein degradation in cultured skeletal muscle from Duchenne muscular dystrophy patients.
    Neville HE; Harrold S
    Muscle Nerve; 1985; 8(3):253-7. PubMed ID: 4058470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabolic steroids and training.
    Hickson RC; Kurowski TG
    Clin Sports Med; 1986 Jul; 5(3):461-9. PubMed ID: 3521896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
    J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysferlin and the plasma membrane repair in muscular dystrophy.
    Bansal D; Campbell KP
    Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.